This map shows the geographic impact of A Floyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Floyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Floyd more than expected).
This network shows the impact of papers produced by A Floyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Floyd. The network helps show where A Floyd may publish in the future.
Co-authorship network of co-authors of A Floyd
This figure shows the co-authorship network connecting the top 25 collaborators of A Floyd.
A scholar is included among the top collaborators of A Floyd based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with A Floyd. A Floyd is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Zywiak, William H., et al.. (1999). Substance abuse treatment cost offsets vary with gender, age, and abstinence likelihood.. PubMed. 26(1). 33–9.17 indexed citations
10.
Fish, Barbara, et al.. (1972). Acute responses of schizophrenic children to a sedative and a "stimulating" neuroleptic: a pharmacologic yardstick.. PubMed. 14(12). 759–66.18 indexed citations
11.
Gershon, S, et al.. (1970). Relative efficacy of butaperazine and chlorpromazine in acute schizophrenia.. PubMed. 12(12). 810–8.2 indexed citations
12.
Gershon, Samuel, et al.. (1969). Cyprolidol and imipramine: a double-blind controlled study in endogenous depression.. PubMed. 19(6). 955–6.1 indexed citations
Fish, Barbara, et al.. (1969). Comparison of trifluperidol, trifluoperazine and chlorpromazine in preschool schizophrenic children: the value of less sedative antipsychotic agents.. PubMed. 11(10). 589–95.16 indexed citations
15.
Fish, Barbara, et al.. (1969). Schizophrenic children treated with methysergide (sansert).. PubMed. 30(8). 534–40.14 indexed citations
16.
Gershon, Samuel, et al.. (1968). Non-correlation of preclinical-clinical evaluation of a prosposed anti-depressant 4-phenyl-bicyclo(2,2,2)octan-1-amine hydrochloride monohydrate (EXP 561).. PubMed. 18(2). 243–5.9 indexed citations
17.
Gershon, S, et al.. (1968). Psycho-activating effects of a new anticonvulsant--CM-6.. PubMed. 10(5). 237–43.5 indexed citations
18.
Gershon, Samuel, et al.. (1968). Discrepancies in the evaluation of an antidepressant, BL-KR 140.. PubMed. 10(6). 282–7.4 indexed citations
19.
Gershon, Samuel, et al.. (1967). Preclinical-clinical correlation of anti-depressant activity: controlled study of gamfexine and imipramine.. PubMed. 9(7). 349–54.4 indexed citations
20.
Floyd, A, et al.. (1967). Clinical trial of an acridane derivative (SKF No. 14,336) in male schizophrenics.. PubMed. 9(1). 17–23.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.